case series:everolimus

2 trials

Sponsors

Department of Pharmacy, Peking University First Hospita, Peking Union Medical College Hospital

Conditions

TSC-associated renal angiomyolipomatuberous sclerosis complex

Phase 4

Efficacy of Everolimus for TSC-associated renal angiomyolipoma

RecruitingChiCTR-OPC-14005488

Peking Union Medical College HospitalTSC-associated renal angiomyolipoma

Start: 2014-11-20Updated: 2017-04-18

Safety and efficacy of everolimus in patients with renal angiomyolipoma associated with tuberous sclerosis: a case series study

RecruitingChiCTR2000039523

Department of Pharmacy, Peking University First Hospitatuberous sclerosis complex

Start: 2020-12-01Updated: 2021-02-01

Related Papers

Assessing the outcomes of everolimus on renal angiomyolipoma associated with tuberous sclerosis complex in China: a two years trial.

2018-03-2732 citations

MP03-06 PRELIMINARY ANALYSIS THE EFFICACY AND SAFETY OF EVEROLIMUS FOR RENAL ANGIOMYOLIPOMA ASSOCIATED TUBEROUS SCLEROSIS IN CHINESE PATIENTS: A SINGLE-CENTRE, SINGLE-ARM, PHASE ? STUDY

The Journal of Urology2016-03-281 citations

MP03-07 RADIOFREQUENCY ABLATION OF PRIMARY TUMORS COMBINED WITH ANTI-PROGRAMMED DEATH-1 (PD-1) ANTIBODY RESULTS IN AN ENHANCED ANTITUMOR EFFECT AGAINST ADVANCED RENAL CELL CARCINOMA

The Journal of Urology2016-03-281 citations